In the wake of a significant recall of applesauce pouches, renewed attention has been drawn to the U.S. Food and Drug Administration’s (FDA’s) food contamination regulatory powers – or the lack thereof. In late October 2023, the FDA issued a safety …
In the UK — England and Wales specifically — October 2023 saw new changes being implemented. In terms of litigation, fixed recoverable cost extensions will cause ripples, and the series of shifts have real potential to upend the market. …
As part of a continued focus on sustainability, the European Commission, Council, and Parliament reached a provisional agreement on the Ecodesign for Sustainable Products Regulation (ESPR) in early December 2023. The new regulation will build on the …
With steadily increasing demand for electric vehicle (EV) — the International Energy Agency expects 14 million sales by year’s end of 2023, a 35% year-over-year increase — the speed at which the industry is required to deliver EV sales wi…
Insurance plays a critical role in our society and economy by providing protection against risk and uncertainty. Every day, the insurance industry makes people whole again after something unexpected occurs. Regrettably, there are a few bad actors who…
As our world becomes more data-driven, safeguarding data and privacy has become a growing focus for businesses and the regulatory agencies that set industry standards. Last year, Gartner forecasted that by the end of 2024, 75% of the world’s populati…
Regulators, lawmakers and technology experts alike seem to agree on two things: artificial intelligence (AI) is an important piece of our future and it needs guidelines for its use. Across the globe, there has been a recent flurry of activity ranging…
After largely pausing onsite facility inspections during the COVID-19 pandemic, the U.S. Food and Drug Administration (FDA) has resumed this type of oversight in the past 18 months. However, several recent in-market events involving contaminated eye …
Frustration with the EU Medical Devices Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR) continues to mount among industry stakeholders over a lack of quick and economical regulatory approval processes. Since the inaction has resulted in s…
Responding to stakeholder concerns, the U.S. Food and Drug Administration (FDA) announced that it will establish a one-year stabilization period for the Drug Supply Chain Security Act (DSCSA) traceability requirements to ensure continuity of the supp…
The U.S. Food and Drug Administration (FDA) continues to work through the redesign of its organizational structure into one unified Human Foods Program (HFP) and recently highlighted its dietary supplements program as a critical priority. In an upd…
In late August, UK Members of Parliament criticised the UK government for failing to lead in regulating artificial intelligence (AI). The criticism came ahead of an AI summit the UK government is hosting in November, and followed the release of a gov…
The risk of product recalls across five key industries remains prevalent in the U.S. according to data from Sedgwick’s latest Recall Index report. Despite recall activity falling less than one percent in Q2 2023 compared to the previous quarter, at o…
European product recalls increased 7.8% in the second quarter of 2023, marking a fourth consecutive quarter of aggregate growth across the automotive, food and beverage, pharmaceutical, medical device and consumer product sectors. According to Sedgwi…
In early August, the government of the United Kingdom released 13 proposals to change product safety. While stakeholders have been expecting these proposals for a while now, a few of the changes came as a surprise to regulatory experts because they c…